LATEST MANUSCRIPTS IN Journal of the Egyptian National Cancer Institute
Avinash Khadela, Bhavin Vyas, Mustakim Mansuri, Dipen Sureja, Kunjan Bodiwala. Impact of cetuximab plus cisplatin alone and cetuximab plus cisplatin and paclitaxel regimen on humanistic outcome in head and neck cancer.Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 1
F Safini, B Amaoui, S Semghouli, N Aqodad. Organ preservation strategy: new therapeutic alternative in rectal cancer.Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 10
Ahmed Daif, Mahmood A Al-Azzawi, Moustafa A Sakr, Hisham A Ismail, Mahmoud Gadallah. Noninvasive identification of molecular biomarkers of hepatocellular carcinoma in HCV-Egyptian patients.Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 11
Eman Mohamad Ibrahim, Sherine Refat, Shaimaa El-Ashwah, Maryan Waheeb Fahmi, Afaf Taha Ibrahiem. Programmed death ligand 1 expression in diffuse large B cell lymphoma: correlation with clinicopathological prognostic factors.Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 12
Ibrahim Abdelrahman, Hatem Aboulkassem, Abdallah Elazab, Ahmed Younis Abdallah, Yahia Ismail, Mohammad Taher. Evaluation of short-term outcomes of neoadjuvant chemotherapy followed by radical cystectomy in muscle-invasive bladder cancer: a single Egyptian institution experience.Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 13
Patrick Odhiambo, Harrison Okello, Annette Wakaanya, Clabe Wekesa, Patrick Okoth. Mutational signatures for breast cancer diagnosis using artificial intelligence.Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 14
Iyshwarya Bhaskar Kalarani, Ganesan Sivamani, Ramakrishnan Veerabathiran. Identification of crucial genes involved in thyroid cancer development.Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 15
Yahia Ismail, Amr Kamal, Rasha Allam, Al-Shimaa Zakaria. The conundrum of metaplastic breast cancer: a single Egyptian institution retrospective 10-year experience (2011-2020).Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 16
Mona S El Ashry, Enas Radwan, Mona S Abdellateif, Omar Arafah, Naglaa M Hassan. Clinical features, laboratory characteristics, and outcome of ETP and TCRA/D aberrations in pediatric patients with T-acute lymphoblastic leukemia.Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 17
Mahdiyar Iravani Saadi, Mohsen Nikandish, Zahra Ghahramani, Fatemeh Mardani Valandani, Maryam Ahmadyan, Fakhroddin Hosseini, Zahra Rahimian, Heeva Jalali, Fataneh Tavasolian, Ehsan Nabi Abdolyousefi, Nadiya Kheradmand, Mani Ramzi. miR-155 and miR-92 levels in ALL, post-transplant aGVHD, and CMV: possible new treatment options.Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 18
Rashed Pourhamidi, Azam Moslemi. Using the Precision Lasso for gene selection in diffuse large B cell lymphoma cancer.Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 19
Alaa Younes, Mohammad Fouad Taher, Iman Sidhom, Wael Zekri, Iman Zaky, Habiba Elfendy, Azza Niazy Taher, Suzan Adlan Khedr, Rana Gamal, Gehad Ahmed. Parotid gland masses: outcomes in the pediatric age group.Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 2
Alex Mwesigwa Mugisha, Zeridah Muyinda, Joyce Balagadde Kambugu, Denise Apolot, Elizabeth Atugonza, Anneth Teu, Aloysius Gonzaga Mubuuke. Observer agreement in single computerized tomography use for diagnosing paediatric head and neck malignancies at Uganda Cancer Institute.Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 20
Mohammed Shahait, Ramiz Abu-Hijlih, Ala'a Farkouh, Shahed Obeidat, Samer Salah, Ahmed Saad Abdlkadir, Akram Al-Ibraheem. Fluorodeoxyglucose positron emission tomography (18F-FDG PET)-computed tomography (CT) in the initial staging of bladder cancer: a single institution experience.Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 21
Seema Sandeep Redekar, Satishkumar L Varma, Atanu Bhattacharjee. Gene co-expression network construction and analysis for identification of genetic biomarkers associated with glioblastoma multiforme using topological findings.Journal of the Egyptian National Cancer Institute. 2023, 35 (1): 22